WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- Even in a setting where white and Black people have equal access to medical care, Black Americans fare worse than whites in terms of prostate cancer, new research shows.
Search / 175 results found Showing: 1-10 of 175
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- Big surprise bills for any colonoscopy done after a positive result from a stool-based screening test will be prevented under new federal rules, a group of U.S. medical organizations say.
TUESDAY, Jan. 18, 2022 (HealthDay News) -- Real-world data show steady improvement in overall survival (OS) for patients with Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL) who experienced relapse after allogeneic hematopoietic cell transplantation (allo-HCT), according to a study published online Jan. 12 in Clinical Cancer Research.
TUESDAY, Jan. 18, 2022 (HealthDay Now) -- Advanced forms of hormone therapy are very effective at keeping prostate cancer in check, but they also can double a man's risk of falling into depression, researchers have found.
TUESDAY, Jan. 18, 2022 (HealthDay News) -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the January issue of Practical Radiation Oncology, recommendations are presented for the use of external beam radiation therapy (EBRT) for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC).
TUESDAY, Jan. 18, 2022 (HealthDay News) -- Among patients with bone and brain metastases who died within 90 days of radiotherapy receipt, 21.6 percent received guideline-nonconcordant therapy, according to a research letter published online Jan. 14 in JAMA Health Forum.
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 10 to 14, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FRIDAY, Jan. 14, 2022 (HealthDay News) -- Full COVID-19 vaccination, including third doses and/or boosters, is recommended for all patients with cancer, with a strong preference for mRNA vaccines, according to expert consensus recommendations published by the National Comprehensive Cancer Network (NCCN).
FRIDAY, Jan. 14, 2022 (HealthDay News) -- The prevalence of colorectal neoplasia observed among younger outpatients undergoing colonoscopies supports the recommendation to lower the screening age for colorectal cancer (CRC) to age 45 years, according to a study published online Jan. 4 in Gastroenterology.